Artificial intelligence — the path towards a healthier world
DATA. DISCOVERY. DIAGNOSES.
Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following and confirm your country of residence. Your confirmation must be true and accurate.
Important: You must read the following before continuing. The following applies to the information following this page, and you are therefore advised to carefully read and approve the following before reading, accessing or making any other use of the following information.
This website and the information contained herein are not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions, the "United States"), Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or Singapore, and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares in, rights or other securities of Aiforia Technologies Plc (the "Company") in the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa and Singapore.
The contemplated initial public offering shall be governed by the laws of Finland. No action has been taken, except in Finland, in order to register the shares or the contemplated initial public offering or for the public offering of shares. The shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws including the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa and Singapore. Documents relating to the contemplated initial public offering, including the documents on this website and the prospectus prepared in accordance with the Prospectus Regulation ((EU) 2017/1129), may not be delivered to persons in the above-mentioned countries by copying or in any way whatsoever. The Company requires that the persons mentioned above in this paragraph inform themselves of the restrictions regarding the distribution and other conveyance outside of Finland as well as restrictions regarding the use of information and observe all such restrictions. Neither the Company nor the Company's representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.
In order to access the information related to the contemplated initial public offering, you must certify the following:
The contemplated initial public offering shall be governed by the laws of Finland. No action has been taken, except in Finland, in order to register the shares in Aiforia Technologies Plc (the "Company") or the contemplated initial public offering or for the public offering of shares. The shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws including the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa and Singapore. Documents relating to the contemplated initial public offering, including the prospectus in accordance with the Prospectus Regulation (EU 2017/1129), may not be delivered to persons in the above-mentioned countries and must not be copied in any way whatsoever. The Company requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company's representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion reject any type of share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.
DATA. DISCOVERY. DIAGNOSES.
The subscription period for Aiforia Technologies Plc’s initial public offering on the First North Growth Market was 29 November–8 December 2021. The final subscription price was EUR 5.01 per share in the institutional offering and in the public offering. Trading in Aiforias’s share commenced on the Nasdaq First North on 10 December. The ISIN code of the Shares is FI4000507934, and the trading code is AIFORIA.
Aiforia Technologies Plc aimed to raise gross proceeds approximately of EUR 27 million by offering a maximum of 5,393,657 new shares of the company for subscription. The number of new shares corresponds to approximately 21.3 per cent of the total number of Aiforia's shares after the offering assuming that the over-allotment option is not exercised. Assuming that the over-allotment option will be exercised in full, the offering consists of in total 5,992,459 Shares, corresponding to 23.1 per cent of the total number of shares after the offering.
The total number of Aiforia's shares after the offering will be 25,366,907 assuming that the over-allotment option is not exercised. Assuming that the over-allotment option will be exercised in full, the total number of Aiforia's shares will be 25,965,709.
Aiforia will receive gross proceeds of approximately EUR 30 million from the offering assuming that the over-allotment option will be exercised in full, and correspondingly approximately EUR 27 million assuming that the over-allotment option will not be exercised.
29 November 2021 | The subscription period for the initial public offering commenced |
8 December 2021 | The subscription period for the public offering ended |
9 December 2021 | The final results of the initial public offering were announced |
10 December 2021 | The offer shares allocated in the public offering were recorded in the book-entry accounts of the investors |
10 December 2021 | Trading in the shares on the First North commenced |
Nordnet Bank acts as the subscription place of the public offering through its online service at www.nordnet.fi/fi/aiforia.
Subscriptions can be made in the online service with bank identifiers of Nordnet, Aktia, Danske Bank, Handelsbanken, Nordea, Oma Säästöpankki, Osuuspankki, POP Pankki, S-Pankki, Säästöpankki and Ålandsbanken.
When submitting a commitment, the price to be paid for the offer shares in the public offering is the maximum price for the preliminary price range i.e. EUR 6.51 per offer share multiplied by the number of offer shares covered by the commitment.
Aiforia is a Finnish company providing image analysis software utilising artificial intelligence (AI). The company’s business model is based on the development and utilisation of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics.
Software solutions offered by Aiforia are aimed at automating diagnostic analyses and the most laborious parts of image-based diagnostics by utilising deep learning AI models and cloud-based image management.
The company intends to use the net proceeds from the initial public offering to support the company's growth strategy predominantly in the following way: approximately 50% to sales and marketing, and approximately 50% to research and development as well as other operational purposes.
Aiforia’s management believes that the following factors, in particular, are the company’s key strengths: